Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | August 1, 2006 |
| Phase: | Phase I |
| Status: | Active, not recruiting |
| NCT ID: | NCT00402766 |
| Study Type: | Interventional |
| Intervention: | Drug: Cisplatin|Drug: Imatinib Mesylate|Drug: Pemetrexed |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | M.D. Anderson Cancer Center|Novartis |
| Ages: | Adult|Senior |
| Enrollment: | 42 |
| Funded By: | Other|Industry |
| First Received: | November 20, 2006 |
| End Date: | |
| Last Updated: | September 30, 2010 |
| Last Verified: | September 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
